Cargando…
Early mortality after chemotherapy as a quality indicator—the leukemia perspective
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692074/ https://www.ncbi.nlm.nih.gov/pubmed/38040680 http://dx.doi.org/10.1038/s41408-023-00956-x |
| _version_ | 1785152862841470976 |
|---|---|
| author | Kantarjian, Hagop Welch, Mary Alma Sasaki, Koji |
| author_facet | Kantarjian, Hagop Welch, Mary Alma Sasaki, Koji |
| author_sort | Kantarjian, Hagop |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10692074 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106920742023-12-03 Early mortality after chemotherapy as a quality indicator—the leukemia perspective Kantarjian, Hagop Welch, Mary Alma Sasaki, Koji Blood Cancer J Editorial Nature Publishing Group UK 2023-12-01 /pmc/articles/PMC10692074/ /pubmed/38040680 http://dx.doi.org/10.1038/s41408-023-00956-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Editorial Kantarjian, Hagop Welch, Mary Alma Sasaki, Koji Early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| title | Early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| title_full | Early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| title_fullStr | Early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| title_full_unstemmed | Early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| title_short | Early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| title_sort | early mortality after chemotherapy as a quality indicator—the leukemia perspective |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692074/ https://www.ncbi.nlm.nih.gov/pubmed/38040680 http://dx.doi.org/10.1038/s41408-023-00956-x |
| work_keys_str_mv | AT kantarjianhagop earlymortalityafterchemotherapyasaqualityindicatortheleukemiaperspective AT welchmaryalma earlymortalityafterchemotherapyasaqualityindicatortheleukemiaperspective AT sasakikoji earlymortalityafterchemotherapyasaqualityindicatortheleukemiaperspective |